Ir para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Palavra solta
Título
Autor
Assunto
Área/Cota
ISBN/ISSN
Tag
Pesquisar
Avançada
Anti-CD20 therapy reduces micr...
Citar
Enviar por SMS
Enviar por email
Imprimir
Exportar registo
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Permanent link
Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis
Show other versions (1)
Detalhes bibliográficos
Main Authors:
Anthony, D
,
Campbell, S
,
Dickens, A
,
Checa, B
,
Kersemans, V
,
Seneca, N
,
Balazs, M
,
Leppert, D
Formato:
Conference item
Publicado em:
2012
Exemplares
Descrição
Other Versions (1)
Registos relacionados
Registo fonte
Registos relacionados
Anti-CD20 Therapy Reduces Microglial Activation and Lesion Volume in Focal Models of Pattern I and Pattern II Multiple Sclerosis
Por: Leppert, D, et al.
Publicado em: (2012)
Anti-CD20 therapy down-regulates lesion formation and microglial activation in pattern I and pattern II rat models of multiple sclerosis
Por: Anthony, D, et al.
Publicado em: (2014)
Anti-CD20 therapy reduces lesion volume and activated microglia in rodent models of multiple sclerosis
Por: Seneca, N, et al.
Publicado em: (2012)
Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
Por: Anthony, D, et al.
Publicado em: (2014)
Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
Por: Anthony, D, et al.
Publicado em: (2009)